Latest Regulatory Milestones News

Page 10 of 57
Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.
Ada Torres
Ada Torres
5 Nov 2025
Taiton Resources has secured regulatory approval to launch its first-ever drilling campaign at the Challenger West project in South Australia, targeting promising gold anomalies near a major existing mine.
Maxwell Dee
Maxwell Dee
5 Nov 2025
Far East Gold has secured a pivotal PIPPIB approval for 9,000 hectares of its Idenburg Gold Project in Papua, Indonesia, clearing a major regulatory hurdle and accelerating its path toward mine development.
Maxwell Dee
Maxwell Dee
5 Nov 2025
Bayan Mining has secured US Bureau of Land Management approval for its Desert Star Project in California, paving the way for field activities and a planned drilling program in 2026. The project’s proximity to major rare earth and gold mines underscores its strategic potential.
Maxwell Dee
Maxwell Dee
5 Nov 2025
Mont Royal Resources Limited will have its trading suspension lifted and resume quotation on the ASX from 5 November 2025 following regulatory compliance.
Maxwell Dee
Maxwell Dee
4 Nov 2025
ASF Group's subsidiary ASF Capital has secured AUSTRAC registration as a Digital Currency Exchange provider, marking a regulatory milestone without commencing crypto operations or holding digital assets.
Claire Turing
Claire Turing
3 Nov 2025
Western Yilgarn NL has significantly expanded its exploration footprint at the Ida Holmes Junction Project to target high-grade gallium mineralisation and secured critical land access for drilling at its West Julimar Bauxite Project in Western Australia.
Maxwell Dee
Maxwell Dee
3 Nov 2025
Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.
Ada Torres
Ada Torres
3 Nov 2025
Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.
Ada Torres
Ada Torres
31 Oct 2025
Kore Potash has made significant strides in financing and early development activities for its Kola Potash Project, while updating environmental assessments to reflect design changes. The company holds a cash balance of US$2.13 million as it prepares for construction.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Kinetiko Energy has reported record gas flow rates from its Brakfontein test wells, renewed critical exploration rights, and signed a joint venture to develop a pilot LNG plant, marking a significant step towards commercial gas production in South Africa.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Lithium Plus Minerals has secured a 20-year mining lease for its Lei Lithium Project, marking a significant step toward production, while its subsidiary Moonlight Resources progresses with an IPO and strategic gold asset acquisition.
Maxwell Dee
Maxwell Dee
31 Oct 2025